Jasper Therapeutics所有資訊

Jasper Therapeutics | SC 13G：超過5%持股股東披露文件-Avidity Partners Management LP(5.1%),Avidity Partners Management (GP) LLC(5.1%)等

03/27 16:32 (美東)

Jasper Therapeutics | 4：持股變動聲明-高管 Mahal Jeetinder Singh

03/12 21:34 (美東)

Jasper Therapeutics | 4：持股變動聲明-高管 MARTELL RON

02/20 19:34 (美東)

Jasper Therapeutics | 4：持股變動聲明-高管 Mahal Jeetinder Singh

02/20 19:34 (美東)

Jasper Therapeutics | 4：持股變動聲明-高管 CROSS HERB

02/20 19:29 (美東)

Jasper Therapeutics | 4：持股變動聲明-高管 Tucker Edwin Jonathan

02/20 19:24 (美東)

Jasper Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Citadel Securities LLC(0.2%),Citadel Securities Group LP(0.2%)等

02/14 18:24 (美東)

Jasper Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Qiming U.S. Healthcare Fund II, L.P.(6.2%),Qiming U.S. Healthcare GP II, LLC(6.2%)等

02/14 17:41 (美東)

Jasper Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Biotechnology Value Fund, L.P.(0%),BVF I GP LLC(0%)等

02/14 09:42 (美東)

Jasper Therapeutics | 4：持股變動聲明- Carlyle Group Inc.

02/12 18:25 (美東)

Jasper Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-The Carlyle Group Inc.(7.1%),Carlyle Holdings I GP Inc.(7.1%)等

02/12 18:05 (美東)

Jasper Therapeutics | 4：持股變動聲明-股東 Velan Capital Investment Management LP

02/09 20:45 (美東)

Jasper Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Velan Capital Investment Management LP(9.8%),Velan Capital Management LLC(9.8%)等

02/09 20:40 (美東)

Jasper Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Sphera Funds Management Ltd.(6.39%),Sphera Global Healthcare GP Ltd.(6.39%)等

02/05 09:17 (美東)

Jasper Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Soleus Capital Master Fund, L.P.(8.8%),Soleus Capital, LLC(8.8%)等

02/02 09:55 (美東)

Jasper Therapeutics | 4：持股變動聲明-董事 WIGGANS THOMAS G

2023/11/30 16:05 (美東)

Jasper Therapeutics | 4：持股變動聲明-董事 WIGGANS THOMAS G

2023/11/22 16:06 (美東)

Jasper Therapeutics | 4：持股變動聲明-董事 WIGGANS THOMAS G

2023/11/20 20:14 (美東)

Jasper Therapeutics | 4：持股變動聲明-董事 WIGGANS THOMAS G

2023/11/02 18:00 (美東)

Jasper Therapeutics | 3：首次持股聲明-董事 WIGGANS THOMAS G

2023/11/02 17:58 (美東)